# TheraCal Materials Versus MTA in Full Pulpotomy

> **NCT07660549** · NA · COMPLETED · sponsor: **Cukurova University** · enrollment: 72 (actual)

## Conditions studied

- Pulpitis - Irreversible

## Interventions

- **OTHER:** Mineral Trioxide Aggregate (MTA)
- **OTHER:** Theracal LC
- **OTHER:** TheraCal PT

## Key facts

- **NCT ID:** NCT07660549
- **Lead sponsor:** Cukurova University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-16
- **Primary completion:** 2025-06-18
- **Final completion:** 2026-04-06
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2026-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07660549

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07660549, "TheraCal Materials Versus MTA in Full Pulpotomy". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07660549. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*